Literature DB >> 27394961

Loss of c-Met signaling sensitizes hepatocytes to lipotoxicity and induces cholestatic liver damage by aggravating oxidative stress.

Luis E Gomez-Quiroz1, Daekwan Seo2, Yun-Han Lee3, Mitsuteru Kitade2, Timo Gaiser4, Matthew Gillen2, Seung-Bum Lee2, Ma Concepcion Gutierrez-Ruiz5, Elizabeth A Conner2, Valentina M Factor2, Snorri S Thorgeirsson2, Jens U Marquardt6.   

Abstract

Recent studies confirmed a critical importance of c-Met signaling for liver regeneration by modulating redox balance. Here we used liver-specific conditional knockout mice (MetKO) and a nutritional model of hepatic steatosis to address the role of c-Met in cholesterol-mediated liver toxicity. Liver injury was assessed by histopathology and plasma enzymes levels. Global transcriptomic changes were examined by gene expression microarray, and key molecules involved in liver damage and lipid homeostasis were evaluated by Western blotting. Loss of c-Met signaling amplified the extent of liver injury in MetKO mice fed with high-cholesterol diet for 30days as evidenced by upregulation of liver enzymes and increased synthesis of total bile acids, aggravated inflammatory response and enhanced intrahepatic lipid deposition. Global transcriptomic changes confirmed the enrichment of networks involved in steatosis and cholestasis. In addition, signaling pathways related to glutathione and lipid metabolism, oxidative stress and mitochondria dysfunction were significantly affected by the loss of c-Met function. Mechanistically, exacerbation of oxidative stress in MetKO livers was corroborated by increased lipid and protein oxidation. Western blot analysis further revealed suppression of Erk, NF-kB and Nrf2 survival pathways and downstream target genes (e.g. cyclin D1, SOD1, gamma-GCS), as well as up-regulation of proapoptotic signaling (e.g. p53, caspase 3). Consistent with the observed steatotic and cholestatic phenotype, nuclear receptors RAR, RXR showed increased activation while expression levels of CAR, FXR and PPAR-alpha were decreased in MetKO. Collectively, our data provide evidence for the critical involvement of c-Met signaling in cholesterol and bile acids toxicity.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Cholestasis; Cholesterol; Oxidative stress; c-Met

Mesh:

Substances:

Year:  2016        PMID: 27394961      PMCID: PMC5131870          DOI: 10.1016/j.tox.2016.07.004

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  44 in total

1.  A bootstrap test for the analysis of microarray experiments with a very small number of replications.

Authors:  Markus Neuhäuser; Karl-Heinz Jöckel
Journal:  Appl Bioinformatics       Date:  2006

2.  Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.

Authors:  Valeska Vollrath; Ana M Wielandt; Mirentxu Iruretagoyena; Jose Chianale
Journal:  Biochem J       Date:  2006-05-01       Impact factor: 3.857

Review 3.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Authors:  Anna C Calkin; Peter Tontonoz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-14       Impact factor: 94.444

4.  Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype.

Authors:  Pal Kaposi-Novak; Ju-Seog Lee; Luis Gòmez-Quiroz; Cédric Coulouarn; Valentina M Factor; Snorri S Thorgeirsson
Journal:  J Clin Invest       Date:  2006-05-18       Impact factor: 14.808

5.  Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair.

Authors:  Chang-Goo Huh; Valentina M Factor; Aránzazu Sánchez; Koichi Uchida; Elizabeth A Conner; Snorri S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-30       Impact factor: 11.205

6.  Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis.

Authors:  Noriko Masubuchi; Masahiro Sugihara; Tomonori Sugita; Katsushi Amano; Masanori Nakano; Tomokazu Matsuura
Journal:  Chem Biol Interact       Date:  2015-08-30       Impact factor: 5.192

7.  Sterol regulatory element binding protein 1 interacts with pregnane X receptor and constitutive androstane receptor and represses their target genes.

Authors:  Adrian Roth; Renate Looser; Michel Kaufmann; Urs A Meyer
Journal:  Pharmacogenet Genomics       Date:  2008-04       Impact factor: 2.089

Review 8.  Oxidative stress: a radical way to stop making bile.

Authors:  Marcelo G Roma; Enrique J Sanchez Pozzi
Journal:  Ann Hepatol       Date:  2008 Jan-Mar       Impact factor: 2.400

9.  Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.

Authors:  Bashar Mohamad; Vaishal Shah; Mykola Onyshchenko; Mohammed Elshamy; Federico Aucejo; Rocio Lopez; Ibrahim A Hanouneh; Razan Alhaddad; Naim Alkhouri
Journal:  Hepatol Int       Date:  2015-11-11       Impact factor: 6.047

Review 10.  Pharmacological evidence for a role of liver X receptors in atheroprotection.

Authors:  Petri T Kovanen; Markku O Pentikäinen
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

View more
  5 in total

1.  Altered Met receptor phosphorylation and LRP1-mediated uptake in cells lacking carbohydrate-dependent lysosomal targeting.

Authors:  Megan Aarnio-Peterson; Peng Zhao; Seok-Ho Yu; Courtney Christian; Heather Flanagan-Steet; Lance Wells; Richard Steet
Journal:  J Biol Chem       Date:  2017-07-19       Impact factor: 5.157

2.  Cholesterol overload in the liver aggravates oxidative stress-mediated DNA damage and accelerates hepatocarcinogenesis.

Authors:  Cristina Enríquez-Cortina; Oscar Bello-Monroy; Patricia Rosales-Cruz; Verónica Souza; Roxana U Miranda; Rafael Toledo-Pérez; Armando Luna-López; Arturo Simoni-Nieves; Rogelio Hernández-Pando; María Concepción Gutiérrez-Ruiz; Diego F Calvisi; Jens U Marquardt; Leticia Bucio; Luis Enrique Gomez-Quiroz
Journal:  Oncotarget       Date:  2017-10-24

3.  Cholesterol Induces Nrf-2- and HIF-1α-Dependent Hepatocyte Proliferation and Liver Regeneration to Ameliorate Bile Acid Toxicity in Mouse Models of NASH and Fibrosis.

Authors:  Yula Kaminsky-Kolesnikov; Einat Rauchbach; Diana Abu-Halaka; Michal Hahn; Carmen García-Ruiz; Jose C Fernandez-Checa; Zecharia Madar; Oren Tirosh
Journal:  Oxid Med Cell Longev       Date:  2020-05-25       Impact factor: 6.543

4.  A Network Pharmacology Study of the Molecular Mechanisms of Hypericum japonicum in the Treatment of Cholestatic Hepatitis with Validation in an Alpha-Naphthylisothiocyanate (ANIT) Hepatotoxicity Rat Model.

Authors:  Sen Ling Feng; Jing Zhang; Hongliu Jin; Wen Ting Zhu; Zhongwen Yuan
Journal:  Med Sci Monit       Date:  2021-03-03

5.  Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.

Authors:  Pierluigi Ramadori; Hannah Drescher; Stephanie Erschfeld; Athanassios Fragoulis; Thomas W Kensler; Christoph Jan Wruck; Francisco Javier Cubero; Christian Trautwein; Konrad L Streetz; Daniela C Kroy
Journal:  Oxid Med Cell Longev       Date:  2017-06-06       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.